Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

Clinical trial NCT01132326 · COMPLETED

Trial details

NCT number: NCT01132326
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Autonomic Failure Dopamine Beta Hydroxylase Deficiency Non-Diabetic Neuropathy Neurogenic Orthostatic Hypotension

Start date: 2009-01-01
Primary completion: 2013-02-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.